Skip to main content
. 2015 Jun 28;7(12):1632–1651. doi: 10.4254/wjh.v7.i12.1632

Table 2.

Currently used and investigational serum tumour markers[101]

Markers Character Cut-off level Sensitivity Specificity Comments
AFP Oncofoetal glycoprotein 10-16 ng/dL 60%-80% 70%-90% Poor marker alone
20 ng/dL 39%-66% 76%-97%
AFP-L3 AFP variant (subtype) 10% 39.9% 93.4% Useful in combination
15% 36.1%-96% 92%-99.5% with other markers
GP73 Golgi-specific membrane protein 10 relative units 69% 86% Promising marker
GPC3 Oncofoetal glycoprotein 2 ng/dL 51% 90% Limited utility as a marker
DCP Abnormal prothrombin 40 mAU/mL 48%-62% 81%-98% Useful in combination
HS-GGT Abnormal prothrombin 5.5 IU/mL 43.8%-74% Not available Non specific
AFU Lysosomal enzyme 870 nmol/mL per hour 82% 71% Lower specificity and poor marker

AFP: Alpha-fetoprotein; AFP-L3: Lens culinaris-reactive AFP; GP73: Golgi protein 73; GPC3: Glypican-3; DCP: Des-gamma-carboxyprothrombin; GGT: Gamma-glutamyl transferase; AFU: Alpha-L-fucosidase.